MIR150 and chronic myelomonocytic leukemia: Interestingly, while the expression of miR-150 was decreased in sorted classical and intermediate monocyte subsets collected from 10 CMML patients before any treatment and compared to healthy donor monocyte subsets, its expression was not decreased in the rare, residual nonclassical monocytes in CMML patients (Fig. 7d, Supplementary Figure 9B, C), suggesting that a fraction of leukemic cells may escape the epigenetic down-regulation of MIR150 gene in these patients.